Patent ID: 9642870
Date: 2017-05-09
CPC Classifications: A61K,A61P,C12N,C12Y

Claim:
1. A method for treating atopic dermatitis in a subject comprising administering to the subject a pharmaceutical composition comprising an immunosuppressant and a transglutaminase 2 inhibitor as active ingredients, wherein the immunosuppressant is cyclosporine or tacrolimus, and the transglutaminase 2 inhibitor is glucosamine, wherein when the immunosuppressant is cyclosporine, the cyclosporine and the glucosamine are included in a weight ratio of 1:10 to 1:500, and wherein when the immunosuppressant is tacrolimus, the tacrolimus and the glucosamine are included in a weight ratio of 1:18 to 1:1,000.